The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Travel Grant Chart for fellowships and CME
Travel Grant chart
The chart below shows the travel grant amounts according to the residence of the ERA Member:
*Refers to all the Countries not included in the ERA geographical area
| Residence of the ERA Member | Amount |
|---|---|
| From Hosting City | € 50 |
| From Hosting Country | € 300 |
| Europe | € 550 |
| Outside Europe* | € 700 |